Alkashgari, H.R.; Ruiz-Jimenez, C.; Stoian, C.; Coats, J.S.; Baez, I.; Chirshev, E.; Martinez, S.R.; Dovat, S.; Francis-Boyle, O.L.; Casiano, C.A.;
et al. TSLP as a Potential Therapy in the Treatment of CRLF2 B Cell Acute Lymphoblastic Leukemia. Int. J. Mol. Sci. 2023, 24, 474.
https://doi.org/10.3390/ijms24010474
AMA Style
Alkashgari HR, Ruiz-Jimenez C, Stoian C, Coats JS, Baez I, Chirshev E, Martinez SR, Dovat S, Francis-Boyle OL, Casiano CA,
et al. TSLP as a Potential Therapy in the Treatment of CRLF2 B Cell Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences. 2023; 24(1):474.
https://doi.org/10.3390/ijms24010474
Chicago/Turabian Style
Alkashgari, Hossam R., Caleb Ruiz-Jimenez, Cornelia Stoian, Jacqueline S. Coats, Ineavely Baez, Evgeny Chirshev, Shannalee R. Martinez, Sinisa Dovat, Olivia L. Francis-Boyle, Carlos A. Casiano,
and et al. 2023. "TSLP as a Potential Therapy in the Treatment of CRLF2 B Cell Acute Lymphoblastic Leukemia" International Journal of Molecular Sciences 24, no. 1: 474.
https://doi.org/10.3390/ijms24010474
APA Style
Alkashgari, H. R., Ruiz-Jimenez, C., Stoian, C., Coats, J. S., Baez, I., Chirshev, E., Martinez, S. R., Dovat, S., Francis-Boyle, O. L., Casiano, C. A., & Payne, K. J.
(2023). TSLP as a Potential Therapy in the Treatment of CRLF2 B Cell Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences, 24(1), 474.
https://doi.org/10.3390/ijms24010474
